Organigram Holdings Inc. Capital expenditures

Capital expenditures of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capital expenditures growth rates and interactive chart. Capital expenditures, commonly known as Capex, are funds used by a company to acquire, upgrade, and maintain physical or intangible assets such as property, buildings, an industrial plant, technology, software or equipment. Capex is often used to undertake new projects or investments by the firm. A company must invest over its lifetime into productive assets to maintain its competitiveness and ensure its survival.


Highlights and Quick Summary

  • Capital expenditures for the quarter ending February 28, 2022 was $-6.78 Million (a 21.57% increase compared to previous quarter)
  • Year-over-year quarterly Capital expenditures increased by 202.07%
  • Annual Capital expenditures for 2021 was $-9.27 Million (a -83.86% decrease from previous year)
  • Annual Capital expenditures for 2020 was $-57.4 Million (a -29.87% decrease from previous year)
  • Annual Capital expenditures for 2019 was $-81.9 Million (a 85.4% increase from previous year)
  • Twelve month Capital expenditures ending February 28, 2022 was $-18.8 Million (a 39.4% increase compared to previous quarter)
  • Twelve month trailing Capital expenditures decreased by -1266.74% year-over-year
Trailing Capital expenditures for the last four month:
28 Feb '22 30 Nov '21 31 Aug '21 31 May '21
$-18.8 Million $-13.5 Million $-9.27 Million $1.61 Million
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capital expenditures of Organigram Holdings Inc.

Most recent Capital expendituresof OGI including historical data for past 10 years.

Interactive Chart of Capital expenditures of Organigram Holdings Inc.

Organigram Holdings Inc. Capital expenditures for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-6.78
2021 $-5.58 $-4.2 $-2.24 $-1.47 $-9.27
2020 $-1.37 $6.69 $-14.81 $-25.93 $-57.45
2019 $-23.39 $-25.33 $-20.13 $-19.7 $-81.91
2018 $-16.75 $-44.18 $-44.18

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic